• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

UC Davis study on eye diseases in kittens

March 21, 2023
Sydney Yankowicz, Assistant Editor

Study shows a complex, but treatable disease with 40 patients

According to a university release1 from UC Davis School of Veterinary Medicine, over the past 20 years, the eye disease symblepharon has only been studied in 5 published papers covering 20 kittens. This condition can be blinding to the car and occurs when the conjunctiva—the pink tissue surrounding the eye—fuses with other nearby surface structures of the eye or eyelid soon after birth, likely secondary to a feline herpesvirus infection on the ocular surface. Symblepharon is commonly seen in feline medicine practice, yet veterinary academic literature has been limited and inconclusive.

UC Davis recently published its own study2 on symblepharon using 40 kittens (in a total of 54 eyes) on February 6, 2023, to retrospectively evaluate the signalment, treatment, surgical technique, and outcomes for feline symblepharon.

“There is a misconception that this disease is not treatable or that it has a high rate of recurrence,” said David Maggs, BVSc (hons), DACVO, a professor of ophthalmology at UC Davis, said in the release. “We were able to separate out that smaller percentage of cases that do recur from those that respond much better to therapy, and to determine that this is not one homogenous disease. Many of these cases were previously being referred for enucleation (removal of eye), but we discovered that almost all these kittens have visual, comfortable eyes that can be saved.”1

The study began with kittens that had a clinical diagnosis of symblepharon between January 1, 2002, and May 31, 2022, identified through a digital search of electronic medical records from the University of California Davis Veterinary Medical Teaching Hospital. All the kittens that participated were less than 1 year of age at the time of initial diagnosis.

The results

Advertisement

There were 5 types of symblepharon found in various combinations: eyelid deformation (24 kittens; 32 eyes); ankyloblepharon (4 kittens; 4 eyes); conjunctiva-to-conjunctiva (11 kittens; 12 eyes); third eyelid-to-conjunctiva (24 kittens; 29 eyes); and corneoconjunctival adhesions (14 kittens; 16 eyes). At initial presentation, 23 (43%) eyes were affected by 1 type of symblepharon, 25 (46%) eyes by 2 types, and 6 (11%) eyes by 3 types.2

Surgery was performed under general anesthesia/sedation (30 occasions) or topical anesthesia (21 occasions) on 30 (56%) eyes of 22 kittens; 12 eyes (40%) underwent multiple surgeries. There were 4 surgical techniques used, including: separation of conjunctival-to-conjunctival adhesions ± eyelid margins (14 eyes); resection of third eyelid adhesions ± temporary tacking of the third eyelid (modified Arlt’s pterygium technique; 18 eyes); en bloc resection of the third eyelid (2 eyes); and separation of corneoconjunctival adhesions (14 eyes).2

From there, the researchers concluded that some forms of the disease were more amenable to surgical treatment than others and the surgery needed was relatively simple in some cases. The study also introduced a new surgical technique for managing this disease.

“By carefully identifying which type of symblepharon a kitten may have, the surgery to correct two of the types could be performed by a general practitioner. This could allow shelter veterinarians to correct the condition at the time of neutering. In fact, many of the surgeries documented in this study were performed by our Community Surgery Service,” said Karen Vernau, DVM, MAS, DACVIM (Neurology), a clinical professor of neurology/neurosurgery who works with many shelters and rescue groups through the Access to Care Program at UC Davis.1

UC Davis undergraduate student, Hikaru (Ray) Shiraishi, took the lead on this study and became acquainted with the Ophthalmology Service through his work with the Vet Aide Club, a student organization that allows undergraduates to gain practical, hands-on experience in a variety of animal care fields. Shiraishi was offered a student position as an animal technician with the Ophthalmology Service and was ultimately recommended by the ophthalmology faculty to take on this research project.

References

  1. Study shows complexity and treatability of eye disease in kittens. News release. UC Davis School of Veterinary Medicine. Published March 17, 2023. Accessed March 20, 2023. https://www.vetmed.ucdavis.edu/index.php/news/study-shows-complexity-and-treatability-eye-disease-kittens
  2. Shiraishi H, Vernau KM, Kim S, et al. Symblepharon in kittens: a retrospective study of 40 kittens and 54 eyes (2002-2022). J Feline Med Surg. 2023;25(2):1098612X221150160. doi:10.1177/1098612X221150160

Related Content:

MedicalFeline MedicineOphthalmology
Drug for acute onset of canine pancreatitis is launched on the US market
Drug for acute onset of canine pancreatitis is launched on the US market
Diagnostics for a thoracic trauma patient
Diagnostics for a thoracic trauma patient
Most important advice this veterinarian received in rehabilitative medicine
Most important advice this veterinarian received in rehabilitative medicine

Advertisement

Latest News

Can our Pride panel answer these LGBTQ+ trivia questions?

Creating inclusive spaces for the LGBTQ+ community in vet med

Happy Pride Month, Hill's launches Prescription Diet ONC Care, and more

CityVet Celina opens in Prosper, Texas

View More Latest News
Advertisement